BioMed Research International / 2018 / Article / Tab 2

Research Article

Assessment of the Hepatitis C Surveillance System in Henan, China: 2014~2016

Table 2

Assessment of Hepatitis C surveillance system in Henan, China: 2014-2016.

Attributes201420152016P values
OVERALLCDHCCHCOVERALLCDHCCHCOVERALLCDHCCHCOVERALLCDHCCHC

Correctly reported cases (A)130075454614965609361224661563
Falsely-reported cases (B)821233588657270387490266224
Underreported-cases (C)62649613038226212023013793

RS=A/(A+C)67.5060.3280.7779.6668.1388.6484.1882.8385.82<0.001<0.001<0.01
UR=C/ (A+C)32.5039.6819.2320.3431.8711.3615.8217.1714.18<0.001<0.001<0.01
PVP=A/(A+B)61.2976.3948.1569.4867.4770.7571.4171.3171.54<0.001>0.01<0.001
FRR=B/ (A+B)38.7123.6151.8530.5232.5329.2528.5928.6928.46<0.001>0.01<0.001

Notes.RS: report sensitivity, UR: underreporting rate, PVP: predictive value positive, FRR: false report rate, CDHC: clinical diagnosed Hepatitis C case, CHC: confirmed Hepatitis C case.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.